Our leadership team

Cancer52’s key strength lies within the expertise and skills of those individuals who give their time to help drive forward the agenda for rare and less common cancers.

All are strong, senior and experienced individuals at board and strategy level, established and credible in their own right.

The board of directors was initially established  in early 2012 alongside the creation of the organisation’s new status as a not for profit company limited by guarantee.  Board membership has been updated since then and still represents a very vibrant and experienced group of people committed to the aims of Cancer52.

This formalisation of status gave Cancer52 a new lease of life in its ability to work in partnership with its members, whilst not placing it in ‘competition’ with any of those organisations, all of which are charities.

The board is responsible for shaping the direction of Cancer52, supporting its Chair Jonathan Pearce and guiding the work of the organisation.